# Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study

Study · id `cardio:ct-nct04331769` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04331769](<https://clinicaltrials.gov/study/NCT04331769>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04331769

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 400 participants.

## Technical summary

Registry record NCT04331769. Randomized; no masking; primary purpose treatment. Start 2020-12-21 (actual); primary completion 2026-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 400 participants (planned count; ClinicalTrials.gov record NCT04331769, source copy `cardio:ctgov-nct04331769-2026-06-03`, retrieved 2026-10-26)
- Started: 2020-12-21 (actual) (ClinicalTrials.gov record NCT04331769, source copy `cardio:ctgov-nct04331769-2026-06-03`, retrieved 2026-10-26)
- Primary completion: 2026-12-31 (anticipated) (ClinicalTrials.gov record NCT04331769, source copy `cardio:ctgov-nct04331769-2026-06-03`, retrieved 2026-10-26)
- Completion: 2030-12-21 (anticipated) (ClinicalTrials.gov record NCT04331769, source copy `cardio:ctgov-nct04331769-2026-06-03`, retrieved 2026-10-26)
- Countries: United States; Belarus; Belgium; Czechia; France; Germany; Greece; Italy; Netherlands; Serbia (ClinicalTrials.gov record NCT04331769, source copy `cardio:ctgov-nct04331769-2026-06-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "SUSPENDED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04331769-2026-06-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study
- Condition: Heart Failure With Reduced Ejection Fraction (HFrEF)
- Condition: Dilated Cardiomyopathy
- Intervention (Device): AccuCinch Ventricular Restoration System
- Intervention (Drug): Guideline-Directed Medical Therapy
- Lead sponsor: Ancora Heart, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Cardiomyopathy (heart muscle disease) (`cardio:cardiomyopathy`)
- Registry condition terms include this condition: Dilated cardiomyopathy (`cardio:dilated-cardiomyopathy`)
- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition term reads as this condition, and the trial is coded with its broader condition: Heart failure with reduced ejection fraction (HFrEF) (`cardio:hfref`)

## Provenance

Content hash: f495c5f591d877ec1a96c310078efd45522509b732379d4b0dd35a55c3c23530
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
